###begin article-title 0
The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells
###end article-title 0
###begin p 1
###xml 252 256 <span type="species:ncbi:10090">mice</span>
The adhesion molecule L1, which is extensively characterized in the nervous system, is also expressed in dendritic cells (DCs), but its function there has remained elusive. To address this issue, we ablated L1 expression in DCs of conditional knockout mice. L1-deficient DCs were impaired in adhesion to and transmigration through monolayers of either lymphatic or blood vessel endothelial cells, implicating L1 in transendothelial migration of DCs. In agreement with these findings, L1 was expressed in cutaneous DCs that migrated to draining lymph nodes, and its ablation reduced DC trafficking in vivo. Within the skin, L1 was found in Langerhans cells but not in dermal DCs, and L1 deficiency impaired Langerhans cell migration. Under inflammatory conditions, L1 also became expressed in vascular endothelium and enhanced transmigration of DCs, likely through L1 homophilic interactions. Our results implicate L1 in the regulation of DC trafficking and shed light on novel mechanisms underlying transendothelial migration of DCs. These observations might offer novel therapeutic perspectives for the treatment of certain immunological disorders.
###end p 1
###begin p 2
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 916 917 916 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 919 920 919 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 250 255 <span type="species:ncbi:10090">mouse</span>
###xml 261 264 <span type="species:ncbi:10116">rat</span>
###xml 647 653 <span type="species:ncbi:9606">humans</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
L1 (also known as L1CAM or CD171) is a transmembrane glycoprotein belonging to the Ig superfamily of cell adhesion molecules (CAMs [Ig-CAMs]), which mediate calcium-independent cell-cell adhesion. The L1 gene is located on the X chromosome in human, mouse, and rat. The extracellular portion of the protein contains six Ig-like domains and five fibronectin type III repeats, followed by a transmembrane region and a cytoplasmic domain (1). L1 has long been characterized as a cell recognition molecule within the nervous system, where it is involved in neurite fasciculation, synaptogenesis, axonal growth and path finding, and cell migration. In humans, mutations in the L1 gene cause abnormal brain development, which is characterized by mental retardation and defects in the central nervous system (2). These neurological alterations were, at least in part, recapitulated in mice where the L1 gene was disrupted (3, 4).
###end p 2
###begin p 3
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
L1-dependent cell-cell adhesion is mediated by the homophilic binding between L1 molecules located on adjacent cells. However, L1 also engages in heterophilic interactions with different molecular partners, including other Ig-CAMs, integrins, and growth factor receptors. These interactions, together with the association of its cytoplasmic tail with a broad spectrum of intracellular partners, endow L1 with the signal-transducing properties that underlie its neural activities (1).
###end p 3
###begin p 4
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 1352 1353 1352 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
Besides the nervous system, L1 expression has been reported in various normal tissues, ranging from some epithelia to certain lineages of the hematopoietic system, as well as in several tumor types. In these nonneuronal tissues, however, L1 function is still poorly understood. Within the hematopoietic system, L1 has been detected in cells of myelomonocytic and lymphoid origin such as lymphocytes and DCs (5). DCs play a key role in the activation of specific immunity, and their trafficking to secondary lymphoid organs is crucial for this function. Indeed, upon microbial contact and stimulation by inflammatory cytokines DCs take up antigens and migrate from peripheral tissues, via the afferent lymphatics, into the T cell area of the draining lymph node where they present the antigens to T lymphocytes, thus triggering the immune response. The migration of DCs into and out of tissues depends on a cascade of discrete events including the induction of chemokines, the activation of chemokine receptors, and the regulation of adhesion molecules. In particular, transendothelial migration is of paramount importance during DC-induced immune response because DCs need to cross both the blood vessel wall, to move from the bloodstream to the peripheral tissue, and the lymphatic endothelium, to reach the lymph nodes via the lymphatic circulation (6). Based on these considerations and on the reported role of L1 in cellular motility and in intercellular recognition, we investigated the involvement of L1 in DC function and, in particular, in the transmigration of DCs across the endothelium.
###end p 4
###begin p 5
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
To this goal, we generated conditional knockout mice in which L1 expression was ablated in the hematopoietic precursors as well as in endothelial cells (ECs). L1-deficient DCs derived from these mice were impaired in both adhesion to the endothelium and in transendothelial migration. Moreover, DC migration to afferent lymph nodes upon contact sensitization was also defective in conditional L1 knockout mice, likely also involving endothelial L1. Thus, we have provided evidence that highlights the important role of L1 in DC trafficking, which may open novel therapeutic perspectives for the treatment of immune disorders.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin title 7
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Generation of conditional L1 knockout mice and characterization of DCs
###end title 7
###begin p 8
###xml 35 36 35 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 174 175 174 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 242 250 242 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 321 322 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 334 335 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
L1 has been detected in human DCs (5). To investigate whether mouse DCs also express L1, we collected lymph node cells from C57BL/6 mice and determined L1 expression in CD11c+ cells. Approximately 55% of DCs were found to be positive for L1 (Fig. 1 A). The analysis of DC subpopulations showed L1 expression in 45% of CD4+, 40% of CD8+, and 40% of B220+ DCs, whereas 85% Langerhans cells were positive for L1 (Fig. S1 A). Similar results were obtained in DCs isolated from the spleen (Fig. S1 B). The widespread expression of L1 in Langerhans cells was also confirmed in the epidermis (see fourth paragraph).
###end p 8
###begin p 9
###xml 38 44 38 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 27 44 27 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ablation of L1 in DCs from <italic>Tie2-Cre;L1<sup>floxed</sup></italic> mice.</bold>
###xml 501 507 501 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 499 507 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 523 529 523 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 512 529 512 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 413 418 <span type="species:ncbi:10090">mouse</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
Ablation of L1 in DCs from Tie2-Cre;L1floxed mice. (A) CD11c-positive cells from the lymph nodes of C57BL/6 mice (left) were gated and analyzed for L1 expression (right). Background staining was determined with a control isotype-matched antibody (black line). The experiment was repeated with lymph nodes from five individual mice with similar results, and the figure refers to one representative analysis of one mouse. (B) FACS analysis of CD11c and L1 coexpression in bone marrow-derived DCs from L1floxed and Tie2-Cre;L1floxed mice. The experiment was repeated with similar results on four individual mice for each genotype, and the figure refers to one representative analysis.
###end p 9
###begin p 10
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 319 325 319 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 317 325 317 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1cam</italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1cam</italic>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1cam</italic>
###xml 744 750 744 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 733 750 733 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 203 218 <span type="species:ncbi:10090">transgenic mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
To gain insight into the role of L1 in DC function, we first undertook a genetic approach in mice. The tyrosine kinase receptor Tie2 is expressed in early precursors of hematopoietic and ECs (7). Hence, transgenic mice expressing Cre recombinase under the control of the Tie2 gene promoter (8) were intercrossed with L1floxed mice carrying two floxed alleles of the L1cam gene (9). The genotype of the mice was determined by PCR on genomic DNA (Fig. S2, A and B). Because the L1cam gene maps on chromosome X (and, therefore, only one copy is present in male genome), Cre-mediated recombination was expected to be more efficient in L1-floxed males. Hence, only Tie2-Cre-positive males carrying the floxed L1cam allele (referred to as Tie2-Cre;L1floxed mice) were used throughout the study.
###end p 10
###begin p 11
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 451 457 451 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 449 457 449 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 473 479 473 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 462 479 462 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 905 911 905 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 894 911 894 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
The correct function of the Tie2-Cre transgene was verified by Cre immunoblotting analysis on undifferentiated bone marrow precursors (Fig. S2 C, top). These precursors showed no expression of L1 at this stage (Fig. S2 C, bottom). The ablation of L1 in Tie2+ hematopoietic progenitors did not cause major defects in mouse hematopoiesis, as blood cell counts for erythrocytes and the different leukocyte populations gave very similar values for both L1floxed and Tie2-Cre;L1floxed littermates (unpublished data). In addition, the loss of L1 did not affect the cellular composition of mouse lymph nodes (Fig. S2 E), including the relative amounts of DC subpopulations (Fig. S2 F). Finally, although Tie2-Cre mice have been used to target genes expressed in ECs (8) and L1 expression in the vessels has been reported under pathological conditions (10, 11), no gross vascular defects were noted in Tie2-Cre;L1floxed mice.
###end p 11
###begin p 12
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 210 218 210 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 304 310 304 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 302 310 302 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 407 415 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 521 527 521 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 510 527 510 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 534 542 534 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
To investigate the role of L1 in DCs, bone marrow precursors were cultured in the presence of GM-CSF, a classical inducer of DC differentiation. This treatment yielded a nearly pure population of CD11c+ cells (Fig. 1 B), confirming their differentiation into DCs. Bone marrow-derived DCs isolated from L1floxed mice exhibited high levels of L1, which is detectable by both FACS and immunoblotting analysis (Fig. 1 B, top; and Fig. S2 D). In contrast, L1 was not detected in DCs derived from the bone marrow of Tie2-Cre;L1floxed mice (Fig. 1 B, bottom; and Fig. S2 D), indicating that Tie2 promoter-driven expression of Cre recombinase results in the ablation of L1 in this cell type.
###end p 12
###begin title 13
The role of L1 in DC adhesion to endothelium and transendothelial migration
###end title 13
###begin p 14
To study the role of L1 in DC biology, we first asked whether this adhesion molecule is involved in the maturation of DCs. Bone marrow-derived DCs were stimulated with LPS and then the expression of classical activation markers was analyzed. The loss of L1 did not affect LPS-induced up-regulation of CD86 (Fig. S3 A), CD80, and MHC class II (not depicted), indicating that DC maturation is not influenced by L1. In addition, the level of L1 was not affected by LPS stimulation of DCs (Fig. S3 B).
###end p 14
###begin p 15
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 200 206 200 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 198 206 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 221 227 221 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 210 227 210 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 400 406 400 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 389 406 389 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 508 514 508 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 506 514 506 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 521 536 521 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, A and B</xref>
###xml 651 657 651 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 640 657 640 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 691 699 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 905 911 899 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 903 911 897 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 927 933 921 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 916 933 910 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 1212 1213 1203 1204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1220 1221 1211 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1346 1354 1337 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1377 1378 1368 1369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1421 1422 1412 1413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1523 1524 1514 1515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1573 1579 1564 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 1562 1579 1553 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 1658 1659 1649 1650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1671 1677 1662 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 1669 1677 1660 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 318 323 <span type="species:ncbi:10090">mouse</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 1580 1584 <span type="species:ncbi:10090">mice</span>
###xml 1678 1682 <span type="species:ncbi:10090">mice</span>
Next, we investigated whether L1 is involved in the interaction of DCs with the lymphatic vessel endothelium, a key process in DC trafficking to lymphoid organs (12). To this goal, DCs derived from L1floxed or Tie2-Cre;L1floxed bone marrows were subjected to adhesion assays on monolayers of lymphatic ECs (LECs). Two mouse LEC lines were used, MELCs (13) and SV-LECs (14). In both cases, Tie2-Cre;L1floxed DCs exhibited a lower adhesion capacity to lymphatic endothelium as compared with DCs from control L1floxed mice (Fig. 2, A and B). Furthermore, L1-positive DCs spread and extended cellular protrusions upon adhesion to LECs, whereas Tie2-Cre;L1floxed DCs retained a round morphology (Fig. 2 B, inset). The stronger adhesion of L1-expressing bone marrow-derived DCs was not the result of an L1-dependent regulation of beta2 integrins because no difference in beta2 expression was observed between L1floxed and Tie2-Cre;L1floxed DCs and the two cell populations adhered to purified ICAM-2 (a major beta2 ligand) with similar efficiency (unpublished data). The role of L1 in the interaction of DCs with the lymphatic endothelium was also assessed using DCs freshly isolated from lymph nodes. In this case, L1+ and L1- DCs were separated by FACS sorting and labeled with different dyes before adhesion assays on SV-LEC monolayers. As shown in Fig. 2 C, lymph node-derived L1+ DCs adhered twice more efficiently than L1- cells to the lymphatic endothelium, confirming the results obtained with bone marrow-derived DCs. L1- DCs isolated from the lymph nodes of Tie2-Cre;L1floxed mice showed an adhesion rate to lymphatic endothelium comparable to that of L1- DCs from L1floxed mice (unpublished data). These results supported the notion that L1 is required for DC-LEC interaction.
###end p 15
###begin p 16
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1 regulates the adhesion of DCs to endothelium.</bold>
###xml 103 109 103 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 125 131 125 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 114 131 114 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 675 681 665 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 673 681 663 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 747 748 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 786 787 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 790 791 780 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 801 802 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 805 806 795 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 692 697 <span type="species:ncbi:10090">Mouse</span>
###xml 1172 1176 <span type="species:ncbi:10090">mice</span>
L1 regulates the adhesion of DCs to endothelium. (A and B) CFSE-labeled bone marrow-derived DCs from L1floxed and Tie2-Cre;L1floxed mice were seeded on TNF-alpha-stimulated MELC (A) or SV-LEC (B) monolayers and allowed to adhere for the indicated time lengths. After washing and fixation, cell adhesion was measured as described in Materials and methods. Data represent the means +/- SD of a single representative experiment performed in triplicate. The experiment was independently repeated five times, each time using DCs from different mice. The insets in B show the morphology of DCs seeded on SV-LEC monolayers. Bar, 10 microm. *, P < 0.05; **, P < 0.005 (relative to L1floxed DCs). (C) Mouse inguinal lymph node cells were enriched for CD11c+ cells and then FACS sorted into CD11c+/L1+ and CD11c+/L1- DCs (top, postsorting cell populations), which were then labeled with CFSE (green) and PKH26 (red), respectively, before adhesion assays on TNF-alpha-stimulated SV-LEC monolayers (bottom left, example of DC adhesion; bar, 30 microm). Data in the bottom right represent the means +/- SD from three independent experiments, each performed with lymph nodes from three mice. *, P < 0.05 (relative to L1-positive DCs).
###end p 16
###begin p 17
###xml 389 397 389 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 480 488 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 814 822 814 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 1412 1418 1412 1418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 1401 1418 1401 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 682 687 <span type="species:ncbi:10090">mouse</span>
We next asked whether the loss of L1 also affected the migration of DCs across a lymphatic endothelial barrier. Both basal-to-apical and apical-to-basal directions were tested to mimic intra- and extravasation of DCs, respectively. By analogy to cell adhesion, the migration rate of L1-deficient DCs through a lymphatic endothelial monolayer was markedly lower than that of control cells (Fig. 3 A). L1 was required for both apical-to-basal and basal-to-apical DC transmigration (Fig. 3 A, left and middle). Moreover, because transendothelial migration of DCs also occurs across the wall of blood vessels (12), we included blood vascular ECs in our transmigration assays, using the mouse EC line 1G11 (15). As in the case of LECs, the loss of L1 resulted in the impairment of DC migration through 1G11 monolayers (Fig. 3 A, right), implicating L1 in the trafficking of DCs across both lymphatic and blood vessel walls. Very similar results were obtained when the transendothelial migration of either immature or mature DCs across lymphatic or blood vessel ECs was stimulated by the chemokines CCL3 or CCL19, respectively (Fig. S4 A). Notably, L1 deficiency by itself did not affect the migratory ability of DCs, as neither the chemotactic migration toward the CCL3 or CCL19 chemokines (Fig. S4 B) nor the motility of DCs within three-dimensional collagen type I matrix (not depicted) were affected in Tie2-Cre;L1floxed DCs. This argued against a cell autonomous effect of L1 on DC motility and further supported its specific involvement in DC-EC interactions.
###end p 17
###begin p 18
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1 is required for DC transendothelial migration and trafficking to lymph nodes.</bold>
###xml 481 487 477 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 479 487 475 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 503 509 499 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 492 509 488 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 821 827 815 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 819 827 813 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 891 897 885 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 889 897 883 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 912 918 906 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 901 918 895 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 1228 1234 1220 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 1226 1234 1218 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
L1 is required for DC transendothelial migration and trafficking to lymph nodes. (A) For apical-to-basal transmigration assays, SV-LEC (left) or 1G11 cells (right) were seeded on the upper side of gelatin-coated Transwell filters and allowed to form dense monolayers. For basal-to-apical migration assays (middle), SV-LECs were cultured on the bottom side of the filters. ECs were pretreated with TNF-alpha before transmigration assays. CFSE-labeled bone marrow-derived DCs from L1floxed and Tie2-Cre;L1floxed mice were added to the upper chamber of Transwell inserts. After 3 h, DC transmigration was measured as described in Materials and methods. Data represent the means +/- SD of representative experiments performed in triplicate with DCs from five mice for each genotype. *, P < 0.05; **, P < 0.005 (relative to L1floxed DCs). (B) FITC skin painting was performed on the abdomen of L1floxed or Tie2-Cre;L1floxed mice. After 24 h, inguinal lymph nodes were excised and subjected to FACS analysis for FITC and CD11c. Data are expressed as the percentage of FITC-positive cells and represent the means +/- SD of a representative experiment (six mice per group) out of three performed. *, P < 0.05 (relative to relative to L1floxed mice). (C) FITC-positive cells in inguinal lymph nodes (left) were gated and analyzed for L1 and CD11c expression (right).
###end p 18
###begin p 19
###xml 258 264 258 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 256 264 256 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 280 286 280 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 269 286 269 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 432 438 432 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 430 438 430 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 700 706 700 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
The difference between L1-proficient and deficient DCs in adhesion to and migration through endothelial barriers was confirmed with DCs obtained from at least five mice for each genotype. Moreover, each experiment was performed comparing DCs isolated from L1floxed and Tie2-Cre;L1floxed littermates to rule out the effect of genetic variability. Nevertheless, to validate these observations in an isogenic model, DCs derived from L1floxed mice were transduced with the Tat-Cre fusion protein, which is known to promote the nuclear translocation of Cre recombinase (16). As a control, cells were treated either with buffer or with an inactive form of Tat-Cre (unpublished data). The transduction of L1floxed DCs with Tat-Cre resulted in the almost complete ablation of L1 expression (Fig. S5 A). This, in turn, caused a dramatic decrease in both apical-to-basal and basal-to-apical transendothelial migration of DCs (Fig. S5 B), thus confirming that the loss of L1 impairs this process. Collectively, these observations point to L1 as an important player in the endothelial adhesion and transendothelial migration of DCs.
###end p 19
###begin title 20
The role of L1 in DC trafficking in vivo
###end title 20
###begin p 21
###xml 300 306 300 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 298 306 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 321 327 321 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 310 327 310 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 470 478 470 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 498 499 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 505 506 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 546 552 546 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 535 552 535 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 593 599 593 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 591 599 591 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 634 635 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 641 642 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 680 686 680 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 678 686 678 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 714 722 714 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 687 691 <span type="species:ncbi:10090">mice</span>
Our in vitro data on the role of L1 in the interaction of DCs with the endothelium might reflect an involvement of this adhesion molecule in the vascular trafficking of DCs in vivo. To address this issue, we performed a series of FITC skin painting assays, in which FITC was applied on the skin of L1floxed or Tie2-Cre;L1floxed mice, and then the uptake of FITC by cutaneous DCs and their trafficking to draining lymph nodes was determined by FACS analysis. As shown in Fig. 3 B, the number of FITC+/CD11c+ cells in the lymph nodes of Tie2-Cre;L1floxed mice was markedly lower than in their L1floxed littermates. More than 85% of FITC+/CD11c+ DCs detected in the lymph nodes of L1floxed mice were positive for L1 (Fig. 3 C), confirming that this molecule is expressed in skin migratory DCs. Collectively, these results indicate that L1 is required for the trafficking of DCs in vivo.
###end p 21
###begin title 22
The role of L1 in Langerhans cell trafficking
###end title 22
###begin p 23
###xml 199 205 199 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 197 205 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 221 227 221 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 210 227 210 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 234 242 234 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 628 636 628 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 893 899 893 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 882 899 882 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 1368 1374 1368 1374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 1366 1374 1366 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 1461 1462 1461 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1468 1469 1468 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1531 1532 1519 1520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1566 1574 1554 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1634 1640 1622 1628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 1623 1640 1611 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 1704 1705 1692 1693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1743 1751 1731 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1868 1876 1856 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1914 1915 1902 1903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2118 2120 2106 2108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 2122 2124 2110 2112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 2598 2604 2586 2592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 2587 2604 2575 2592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 2718 2724 2706 2712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 2716 2724 2704 2712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 2740 2746 2728 2734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 2729 2746 2717 2734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 3191 3197 3179 3185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 3180 3197 3168 3185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 450 455 <span type="species:ncbi:10090">mouse</span>
###xml 460 465 <span type="species:ncbi:9606">human</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 962 967 <span type="species:ncbi:10090">mouse</span>
###xml 1375 1379 <span type="species:ncbi:10090">mice</span>
###xml 1641 1645 <span type="species:ncbi:10090">mice</span>
###xml 2311 2315 <span type="species:ncbi:10090">mice</span>
###xml 2605 2609 <span type="species:ncbi:10090">mice</span>
###xml 2747 2751 <span type="species:ncbi:10090">mice</span>
###xml 3198 3202 <span type="species:ncbi:10090">mice</span>
To investigate whether the loss of L1 affects DC-dependent immune response, we focused on skin immunity and performed contact hypersensitization assays. However, no difference was observed between L1floxed and Tie2-Cre;L1floxed mice (Fig. 4 A). Because skin immunity has been proposed to implicate dermal DCs rather than Langerhans cells (17, 18), we asked whether L1 expression is restricted to specific subtypes of cutaneous DCs. The costaining of mouse and human skin tissues for L1, CD11c, and the Langerhans cell-specific marker Langerin revealed that L1 is specifically expressed in Langerhans cells but not in dermal DC (Fig. 4 B and Fig. S6). The staining of epidermal sheets confirmed that L1 expression is a general feature of Langerhans cells (Fig. S7). The absence of L1 in dermal DCs provided a possible explanation for the unaffected contact hypersensitivity (CHS) in Tie2-Cre;L1floxed mice. Indeed, when fluorescent latex beads were injected into mouse derma to track the migration of dermal DCs or of infiltrating monocytes to draining lymph nodes (19), we found no difference in DC migration in the presence or absence of L1 (Fig. S4 C). These observations pointed to L1-expressing Langerhans cells as the most prominent DC type that migrates to lymph nodes upon skin painting. This hypothesis was confirmed by a FACS analysis on the lymph nodes of L1floxed mice subjected to TRITC skin painting assays, which revealed that almost 100% of TRITC+/CD11c+ cells are Langerhans cells and that approximately97% of TRITC+ cells coexpress langerin and L1 (Fig. 4 C, left). When the same analysis was performed in Tie2-Cre;L1floxed mice, we observed a dramatic decrease (about fourfold) in TRITC+ Langerhans cells in the lymph nodes (Fig. 4 C, right), which correlated with the efficiency of Cre-mediated ablation of L1 (not depicted). This is exemplified in Fig. 4 C (right), where, of the residual TRITC+ cells that migrated to the lymph nodes, the majority expressed L1. Previous studies using TRITC skin painting assays reported that, besides Langerhans cells, dermal DCs also migrate to the lymph nodes (18, 20), an event which was not observed under our experimental conditions. Although the reason for such a discrepancy remains unclear, it may depend on the different genetic background of the mice used in those studies (129/SV;BALB/c) as compared with ours (C57BL/6). Our data further support the notion that L1 is critical for Langerhans cell trafficking. The reduction in Langerhans cell migration was not caused by a lower number of Langerhans cells in the skin of Tie2-Cre;L1floxed mice because we found no difference in the distribution and density of Langerhans cells and dermal DCs between L1floxed and Tie2-Cre;L1floxed mice (unpublished data). Overall, these results indicate that in the skin Langerhans cells are the only DC type expressing L1 and are affected by L1 deficiency in their ability to migrate in vivo. It is noteworthy, however, that the skin painting procedure induced L1 expression in skin vessels (unpublished data). Thus, vascular L1 could contribute to Langerhans cell migration, accounting to some extent for the defect observed in Tie2-Cre;L1floxed mice, where L1 is also ablated in the endothelium.
###end p 23
###begin p 24
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1 is not required for CHS but is involved in Langerhans cell trafficking.</bold>
###xml 103 109 103 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 124 130 124 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 113 130 113 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 648 649 648 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 708 709 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 718 719 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 902 908 898 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 900 908 896 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 930 936 926 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 919 936 915 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 1099 1100 1095 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
###xml 1252 1257 <span type="species:ncbi:10090">mouse</span>
L1 is not required for CHS but is involved in Langerhans cell trafficking. (A) CHS was determined in L1floxed or Tie2-Cre;L1floxed mice by ear-swelling assay at different time points (six mice per genotype), as described in Material and methods. Error bars show the SD among the six individual mice of the same genotype. (B) Skin tissue sections from C57BL/6 mice were subjected to immunofluorescence triple staining for CD11c, Langerin, and L1, followed by confocal analysis. The images were taken from a single confocal plane. The dashed line indicates the boundary between epidermis (left) and dermis (right). Arrowheads indicate CD11c+/Langerin+ Langerhans cells that express L1 and arrows indicate CD11c+/Langerin- dermal DCs that do not express L1. Asterisks indicate an L1-positive nerve that served as internal control. DAPI staining (right) was used to visualize nuclei. Bar, 10 microm. (C) L1floxed (left) or Tie2-Cre;L1floxed (right) mice were subjected to TRITC skin painting, followed by excision of inguinal lymph nodes after 48 h and FACS analysis for CD11c, langerin, and L1 on TRITC+-gated cells. Four mice were analyzed individually for each genotype, giving similar results, and the figure refers to a representative analysis of one mouse per genotype.
###end p 24
###begin title 25
###xml 52 57 <span type="species:ncbi:9606">human</span>
The role of L1 in the transendothelial migration of human DC
###end title 25
###begin p 26
###xml 242 250 242 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 882 890 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 938 940 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 986 994 978 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 1235 1243 1227 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 1399 1407 1391 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 39 45 <span type="species:ncbi:10090">murine</span>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 387 392 <span type="species:ncbi:10090">mouse</span>
###xml 679 684 <span type="species:ncbi:9606">human</span>
###xml 1543 1548 <span type="species:ncbi:10090">mouse</span>
###xml 1619 1624 <span type="species:ncbi:9606">human</span>
Given the difference between human and murine immune systems, we asked whether L1 is also involved in the transendothelial migration of human DCs. To this goal, we used human monocyte-derived DCs (moDCs), which express moderate levels of L1 (Fig. 5 A; reference 5). The maturation of human moDCs was not accompanied by changes in L1 levels (not depicted), confirming our observations on mouse bone marrow-derived DCs (Fig. S3 B). To evaluate the role of L1 in transendothelial migration, CFSE-labeled moDCs were pretreated with CE7, a monoclonal antibody that has been previously shown to neutralize L1 function (21), and then allowed to cross a monolayer of TNF-alpha-activated human umbilical vein ECs (HUVECs). The inactivation of L1 in moDCs with CE7 resulted in a dramatic reduction of the transendothelial migration as compared with moDCs treated with an irrelevant antibody (Fig. 5 B). Given the expression of L1 in activated ECs (10) as well as in TNF-alpha-treated HUVECs (see Fig. 7 A), we also assessed the contribution of vascular L1 to DC transendothelial migration by pretreating HUVECs with CE7 before transmigration assays. The inactivation of endothelial L1 caused a reduction in the transmigratory activity of moDCs (Fig. 5 B). Finally, when L1 was neutralized in both DCs and HUVECs, no additive effect was observed as compared with the inactivation in the individual cell types (Fig. 5 B). Notably, CE7 had no effect on chemokine-induced migration of moDCs (not depicted), which is in line with the results on L1-deficient mouse DCs (Fig. S4 B). Thus, L1 function is required for the trafficking of human DCs through an endothelial barrier.
###end p 26
###begin p 27
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1 function is required for transendothelial migration of human DCs.</bold>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
L1 function is required for transendothelial migration of human DCs. (A) The expression of L1 in human moDCs was assessed by FACS analysis. (B) CFSE-labeled moDCs were subjected to transmigration assays through HUVEC monolayers (see Materials and methods) for 2 h. moDCs, HUVECs, or both cell types were pretreated with 30 microg/ml of anti-L1 CE7 monoclonal antibody or a control isotype-matched anti-hemagglutinin (HA) antibody before transmigration assays. Data represent the means +/- SD of a representative experiment performed in triplicate. The experiment was independently repeated three times. *, P < 0.005 (relative to cells treated with anti-HA antibody).
###end p 27
###begin title 28
L1 homophilic binding in DC-endothelium interaction
###end title 28
###begin p 29
###xml 779 785 779 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 1215 1230 1208 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7, A and B</xref>
###xml 1260 1268 1253 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 1584 1595 1573 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7, D&#8211;F</xref>
###xml 1686 1697 1671 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7, G&#8211;I</xref>
###xml 1867 1869 1852 1854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 2728 2734 2709 2715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 2726 2734 2707 2715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 2749 2755 2730 2736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 2738 2755 2719 2736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 2780 2786 2761 2767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 2778 2786 2759 2767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 3029 3035 3010 3016 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 3018 3035 2999 3016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 430 435 <span type="species:ncbi:9606">human</span>
###xml 440 446 <span type="species:ncbi:10090">murine</span>
###xml 1458 1462 <span type="species:ncbi:10090">mice</span>
###xml 1578 1582 <span type="species:ncbi:10090">mice</span>
###xml 1680 1684 <span type="species:ncbi:10090">mice</span>
###xml 2158 2164 <span type="species:ncbi:10090">murine</span>
###xml 2186 2191 <span type="species:ncbi:9606">human</span>
The results on the transmigration of moDCs through HUVEC monolayers appeared to implicate the homophilic interaction of L1 on DC surface with L1 expressed on ECs. To test this hypothesis, we first determined whether ECs express L1. Immunofluorescence and immunoblotting experiments revealed the presence of L1 in several primary cell populations isolated from the endothelium of lymphatic and blood vessels derived from different human and murine organs, as well as in established EC lines (Fig. S8, A and B). We also investigated the endothelial expression of L1 in vivo by immunohistochemistry. L1 was absent from normal quiescent vasculature (not depicted), but it was detected on the vessels associated to pathological conditions such as neoplastic or inflammatory diseases (Fig. 6), confirming and extending previous observations (10, 22). Because this suggested that the expression of L1 is regulated by tumor- or inflammatory cell-derived factors, we treated ECs with inflammatory cytokines, followed by the assay for L1 expression. Although LPS, IL-1beta, and IL-3 had no effect on L1 levels in HUVEC and 1G11 cells (not depicted), a marked up-regulation was induced by TNF-alpha, as observed both by FACS (Fig. 7, A and B) and by quantitative RT-PCR (Fig. 7 C), the latter implying a regulation at the messenger RNA level. To verify whether TNF-alpha induced the expression of vascular L1 also in vivo, the cytokine was injected subcutaneously into mice, followed by costaining of skin sections for PECAM-1 and L1. Although no L1 was detected in the vessels of control mice (Fig. 7, D-F), high levels of L1 were found in PECAM-1-positive endothelium of TNF-alpha-treated mice (Fig. 7, G-I), confirming this inflammatory cytokine as a strong inducer of L1 expression in the vasculature. Costaining for PECAM-1 and the lymphatic vessel-specific marker LYVE-1 (23) revealed that TNF-alpha-induced expression of L1 occurred in both blood and lymphatic endothelium (Fig. S8 C). These findings provided the rationale for testing whether L1 homophilic interactions accounted for the adhesion of DCs to the endothelium. Indeed, L1-expressing DCs, both from murine bone marrow and from human monocytes, adhered to gelatin supplemented with the extracellular portion of L1 much more efficiently than to L1-free gelatin (Fig. S9 A). In contrast, L1-deficient DCs failed to adhere to L1-containing substrates (Fig. S9 A). In an attempt to mimic the inflammation-associated induction of endothelial L1 and to recapitulate L1 homophilic binding during DC-endothelium interaction, 1G11 ECs were transduced with L1 complementary DNA (cDNA) or with an empty vector (Fig. S9 B) and then used for transendothelial migration assays with L1floxed or Tie2-Cre;L1floxed DCs. Notably, control L1floxed DCs exhibited a significantly higher rate of transmigration across L1-expressing 1G11 monolayers than mock-transduced cells. In contrast, the forced expression of L1 in 1G11 cells had no effect on the transendothelial migration of Tie2-Cre;L1floxed DCs (Fig. S9 C). Collectively, these findings support the notion that the interaction between DCs and ECs implicates the homophilic binding of L1 molecules expressed on the two cell types.
###end p 29
###begin p 30
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1 expression in pathological vessels.</bold>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 394 402 <span type="species:ncbi:9606">patients</span>
L1 expression in pathological vessels. Tissue sections from human synovitis, ovarian, colon, or breast carcinoma were subjected to immunohistochemical staining for L1. Arrows indicate L1 staining associated with the vessel wall, whereas the arrowhead in D indicates an L1-positive nerve that served as the internal control. The staining was performed on sections from at least four independent patients for each disease. Bars, 50 microm.
###end p 30
###begin p 31
###xml 0 47 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945; induces L1 expression in endothelium.</bold>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
TNF-alpha induces L1 expression in endothelium. (A) HUVEC or 1G11 cells were starved of serum and endothelial growth factors and then treated with 20 ng/ml TNF-alpha for 3 h, followed by FACS analysis for L1 expression. (B) HUVEC were treated with 20 ng/ml TNF-alpha for the indicated time lengths, followed by FACS analysis for L1 expression. The data refer to the percentage of L1-positive cells in a representative experiment. Each experiment was repeated three times with similar results. (C) HUVECs were treated with 20 ng/ml TNF-alpha for the indicated time lengths before isolation of RNA and quantitative RT-PCR analysis for L1 expression. Data represent the means +/- SEM of three experiments performed. *, P < 0.05 (relative to untreated cells). (D-I) C57BL/6 mice (three mice per group) were subjected to subcutaneous injection of 100 microl of either vehicle (D-F) or 40 ng/ml TNF-alpha (G-I) and sacrificed after 16 h. Skin fragments from the injection sites were fixed and costained for PECAM-1 (red) and L1 (green) before confocal analysis. Insets show a blood vessel cross section with the ECs positive for both PECAM-1 and L1. The arrow in F indicates an L1-positive nerve that served as an internal control. Bars, 40 microm.
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 691 696 <span type="species:ncbi:9606">human</span>
The contribution of L1 to various developmental processes in the nervous system has long been known. Recent studies have also implicated L1 in the aggressiveness of different tumor types of nonneural origin such as colon cancer (24), melanoma (25), and ovarian carcinoma (21, 26). However, the functional role of L1 in normal tissues outside the nervous system has remained elusive. With regard to DCs, previous work has shown the expression of L1 in this cell type (5) and its contribution to DC-dependent activation of T cells (27). In the present study, we addressed the role of L1 in DCs in greater detail by combining a genetic approach in mice with antibody-mediated neutralization in human DCs. Our results highlighted a novel function of L1 in promoting DC trafficking both in vitro and in vivo. In particular, L1 is involved in the adhesion of DCs to the endothelium and in their transmigration through endothelial barriers. Interestingly, L1 mediates both apical-to-basal and basal-to-apical transendothelial migration of DCs, suggesting an involvement in both extra- and intravasation, respectively. However, the L1-dependent migration of DCs was not a universal characteristic of skin DCs, and only L1-deficient Langerhans cells were affected in their migratory properties in vivo. The functional significance of this property remains to be elucidated.
###end p 33
###begin p 34
###xml 768 770 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 892 894 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 896 898 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 900 902 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 1017 1019 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 1084 1085 1076 1077 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1089 1090 1078 1079 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1189 1191 1178 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 1357 1359 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 1545 1547 1534 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 2245 2246 2226 2227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 2352 2358 2333 2339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 2341 2358 2322 2339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 1955 1960 <span type="species:ncbi:9606">human</span>
###xml 2359 2363 <span type="species:ncbi:10090">mice</span>
L1-expressing DCs were able to cross an L1-negative endothelium (Fig. S9 C), likely implicating heterophilic interactions with different partners on EC surface. However, the forced expression of L1 in ECs results in a marked enhancement of DC transmigration (Fig. S9 C), which is consistent with the hypothesis that, during inflammation, the induction of L1 expression in vessels (e.g., triggered by TNF-alpha) potentiates the transendothelial trafficking of DCs. Although the heterophilic binding partners of L1 involved in DC-EC interactions remain elusive, members of the integrin family are suitable candidates. Indeed, the cross talk between integrins and Ig-like CAMs, such as members of the ICAM and JAM families, is a key step during leukocyte transmigration (28). In support of this hypothesis, not only has L1 been reported to interact with integrins in other experimental systems (10, 29, 30) but L1 homophilic binding upon cell-cell adhesion has been shown to promote integrin recruitment and activation (31). In this context, L1-mediated stimulation of the integrin alphavbeta3 favors the interaction of melanoma with ECs, a process that precedes melanoma cell intravasation (32). The inflammation-associated induction of L1 expression in ECs is intriguing. Despite the fact that L1-positive vessels in inflammatory lesions have been reported (10) and confirmed by our immunohistochemical analysis, L1 has not been investigated as part of the adhesion molecule repertoire that is induced by inflammatory stimuli in the endothelium (28). Our study provides the first evidence that L1 is indeed a transcriptional target of an inflammatory cytokine, such as TNF-alpha, in ECs. In vivo, L1 is not expressed on ECs under steady-state conditions but it is up-regulated after TNF-alpha treatment, supporting the notion that this event is part of the inflammatory reaction rather than a phenomenon restricted to cultured ECs. Based on our results on human ECs where the neutralization of L1 causes a reduction in DC transmigration, it is conceivable that inflammation-induced vascular L1 serves the function of enhancing the transendothelial trafficking of DCs. In this context, the Tie2-Cre transgene is also expressed in the endothelium (8), implying that the induction of vascular L1 under inflammatory conditions would not occur in Tie2-Cre;L1floxed mice. The possibility that endothelial L1 contributes to DC trafficking presents an attractive hypothesis that deserves further investigation. Moreover, although our data suggest that L1 on DCs establishes heterophilic interactions with EC surface molecules (see beginning of paragraph), it remains to be established whether endothelial L1 also binds to different molecules on the surface of DCs. This would implicate a complex network of L1-mediated interactions in DC transendothelial migration during inflammation.
###end p 34
###begin p 35
###xml 280 286 280 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 269 286 269 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 932 938 932 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 921 938 921 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 776 781 <span type="species:ncbi:10090">mouse</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
In spite of L1's role in DC transendothelial migration in vitro and trafficking in vivo, contact hypersensitization was not affected in mice with L1-deficient DCs. This might be accounted for by the residual fraction of DCs that migrated to the draining lymph nodes in Tie2-Cre;L1floxed mice, which would have been sufficient to induce specific immunity. Another explanation (not mutually exclusive with the previous one) relies on the fact that contact hypersensitization assays reflect the induction of skin immunity, which is mediated by Langerhans cells and dermal DCs. Recent studies have specifically implicated dermal DCs in contact hypersensitization (18), whereas Langerhans cells would not be involved in this process (17). Collectively with our observation that in mouse skin L1 is expressed in Langerhans cells but not in dermal DCs, this likely accounts for the normal contact hypersensitization response of Tie2-Cre;L1floxed mice. Future studies should address the impact of L1 deficiency in different types of immune response that involve DCs in compartments other than the skin because the role of L1 in T cell activation has also been reported (27).
###end p 35
###begin p 36
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
Our observation that L1 is found in specific subpopulations of DCs (e.g., Langerhans cells, bone marrow DCs, and moDCs but not dermal DCs or 45% of lymph node DCs) raises the hypothesis that the microenvironment is involved in the modulation of L1 expression in DCs in a tissue-specific manner. Along this line, we have previously reported that intestinal epithelium plays a pivotal role in determining the phenotype of DCs (33). Hence, the regulation of L1 expression might be part of the "education" of DCs by the local environment, which would enable DCs to carry out specialized functions that are required to deal with tissue-associated challenges.
###end p 36
###begin p 37
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
Although the biological significance of L1 expression on cancer-associated vasculature remains elusive, it is tempting to speculate that endothelial L1 in tumors triggers the trafficking of DCs in the absence of an overt inflammation, resulting in the migration to lymph nodes of immature nonimmunogenic DCs (19). These cells could present tumor antigenic peptides in a tolerogenic fashion, thus contributing to tumor immunoevasion.
###end p 37
###begin p 38
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 614 615 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 1310 1311 1310 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 434 440 <span type="species:ncbi:9606">humans</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
###xml 954 962 <span type="species:ncbi:9606">patients</span>
###xml 1053 1061 <span type="species:ncbi:9606">patients</span>
###xml 1352 1360 <span type="species:ncbi:9606">patients</span>
The impairment of DC trafficking upon loss of L1 might have important clinical implications. Other mouse models have revealed a role of L1 in the immune system, although not directly involving DCs. In L1-deficient mice, the architecture of the white pulp border in the spleen was disrupted (34), and L1 was implicated in the tissue remodelling of lymph nodes that occurs during the immune response (35). With regard to L1 function in humans, mutations in the L1 gene cause various neurological disorders that are grouped under the name L1 syndrome (2). This phenotype is largely recapitulated in L1 knockout mice (4, 36-38). Although patients carrying L1 mutations are thoroughly examined for brain development and functions, no information is available on their immune system. Our findings raise the possibility that L1 syndrome is associated with a defective DC trafficking and provide the rationale for investigating the impact of L1 mutations on the patients' immune response. Besides the possible benefit for the clinical management of L1 syndrome patients, such an approach might also contribute to assign the DC-regulatory function of L1 to specific domains and/or residues of the protein. Indeed, numerous syndrome-associated L1 mutations have been described, which are distributed across all domains (2). Hence, the analysis of DC function in patients carrying different L1 mutations would help to determine the relative contribution of individual L1 domains to DC trafficking.
###end p 38
###begin p 39
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 463 471 <span type="species:ncbi:9606">patients</span>
Our study also points to L1 as a potential therapeutic target to modulate DC function, a notion which is supported by the blockade of transendothelial migration of human DCs upon inactivation of L1. In this context, the design of L1-targeting strategies in vivo would benefit both from preclinical studies where L1-neutralizing antibodies showed therapeutic efficacy in tumor-bearing mice (21, 39) and from the use of L1 antibodies for imaging purposes in cancer patients (40). These studies strengthen the rationale for assessing the inhibition of L1 as a strategy to repress DC trafficking in certain immunological disorders.
###end p 39
###begin title 40
MATERIALS AND METHODS
###end title 40
###begin title 41
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 41
###begin p 42
###xml 2 8 2 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 15 16 15 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre</italic>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 295 301 295 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 284 301 284 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 310 316 310 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 308 316 308 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 117 132 <span type="species:ncbi:10090">transgenic mice</span>
###xml 184 189 <span type="species:ncbi:10090">mouse</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
L1floxed mice (9) were provided by M. Schachner and F. Morellini (University of Hamburg, Hamburg, Germany). Tie2-Cre transgenic mice (8) were provided by E. Dejana (Milan, Italy). All mouse strains were backcrossed into the C57BL/6 background for eight or more generations. To obtain Tie2-Cre;L1floxed mice, L1floxed females were crossed with Tie2-Cre males. Genomic DNA of the offspring was isolated from tail biopsies and the genotype was determined by PCR (supplemental Materials and methods). All experiments were performed in accordance with the guidelines established in the Principles of Laboratory Animal Care (directive 86/609/EEC) and approved by the Italian Ministry of Health.
###end p 42
###begin title 43
Antibodies
###end title 43
###begin p 44
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 78 81 <span type="species:ncbi:10116">rat</span>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
###xml 122 125 <span type="species:ncbi:10116">rat</span>
###xml 167 173 <span type="species:ncbi:9986">rabbit</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 241 247 <span type="species:ncbi:9986">rabbit</span>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
###xml 341 346 <span type="species:ncbi:9606">human</span>
###xml 417 420 <span type="species:ncbi:10116">rat</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 506 511 <span type="species:ncbi:9606">human</span>
The following antibodies were used: hamster anti-mouse CD11c (clone HL3; BD); rat anti-mouse PECAM-1 (clone MEC13.3; BD); rat anti-Langerin (clone 929F3; Dendritics); rabbit anti-human L1 ectodomain (from M. Schachner, Hamburg, Germany) and rabbit anti-human L1 cytoplasmic tail pcyt-L1 (from V. Lemmon, Miami, FL; reference 41); mouse anti-human L1 (clone CE7; from K. Blaser, Davos, Switzerland; reference 42); and rat anti-L1 (clones I4.2 and S10.33) generated against mouse L1 (but cross reacting with human L1; unpublished data) and characterized in our laboratory.
###end p 44
###begin title 45
Cells
###end title 45
###begin title 46
DCs.
###end title 46
###begin p 47
###xml 116 122 116 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 114 122 114 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 137 143 137 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 126 143 126 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 336 342 336 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 334 342 334 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 357 363 357 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 346 363 346 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
Bone marrow-derived immature DCs were generated from single cell suspensions of marrow from femurs of 8-10-wk-old L1floxed or Tie2-Cre;L1floxed male mice. After 10-11 d of culture in GM-CSF-containing DC medium (43, 44), the homogeneity of DCs was evaluated by FACS analysis with anti-CD11c (BD). No differences were observed between L1floxed or Tie2-Cre;L1floxed bone marrow precursors in the proliferation rate or in the yield of CD11c-expressing DCs during GM-CSF-induced differentiation (unpublished data).
###end p 47
###begin p 48
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human moDCs were obtained from healthy volunteers as described previously (45). After 5-7 d of culture, cells were analyzed for DC markers and used for functional assays.
###end p 48
###begin title 49
ECs.
###end title 49
###begin p 50
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 539 540 539 540 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 345 350 <span type="species:ncbi:9606">human</span>
The mouse blood vessel EC line 1G11, isolated from the lung, was provided by A. Vecchi (Milan, Italy) and cultured as previously described (15). The mouse LEC lines MELC (46) and SV-LEC (14) were provided by A. Vecchi (Milan, Italy) and J.S. Alexander (Shreveport, LA), respectively, and were cultured as previously described. Primary LECs from human prostate were isolated and cultured as previously described (47) and used between passages 3 and 6. HUVECs (PromoCell) were cultured in MCDB 131 medium (Invitrogen) supplemented with 2 mM l-glutamine, 20% FBS, 50 microg/ml heparin, and 50 microg/ml EC growth supplement (Sigma-Aldrich). 1G11 cells, MELCs, SV-LECs, and HUVECs were seeded on 0.1-1% gelatin. Prostate LECs were cultured on plates coated with 10 microg/ml fibronectin (Sigma-Aldrich). Where specified, ECs were treated with 20 ng/ml TNF-alpha (PeproTech) for the indicated time points.
###end p 50
###begin title 51
Immunohistochemistry
###end title 51
###begin p 52
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 204 215 <span type="species:ncbi:3704">horseradish</span>
Immunohistochemistry on formalin-fixed paraffin-embedded tissue sections was performed as described previously (26) using the polyclonal antibody pcyt-L1. Staining of sections was visualized with the ABC horseradish peroxidase kit (Vector Laboratories) and DAB peroxidase substrate (Sigma-Aldrich). For morphological analysis, tissues were counterstained with hematoxylin.
###end p 52
###begin title 53
FACS
###end title 53
###begin p 54
###xml 160 165 <span type="species:ncbi:10090">mouse</span>
###xml 354 360 <span type="species:ncbi:9986">rabbit</span>
###xml 366 371 <span type="species:ncbi:9606">human</span>
###xml 439 445 <span type="species:ncbi:9986">rabbit</span>
FACS analysis was performed on bone marrow-derived DCs, lymph node-derived cells, and ECs. In brief, cells were resuspended in RPMI medium containing 1% normal mouse serum and then incubated with the specific fluorophore-conjugated antibody. Cells were then analyzed by a FACSCalibur apparatus (BD). For FACS analysis on HUVEC, cells were incubated with rabbit anti-human L1 ectodomain antibody followed by Alexa Fluor 488-conjugated anti-rabbit antibody (Invitrogen).
###end p 54
###begin title 55
Quantitative RT-PCR analysis
###end title 55
###begin p 56
###xml 709 711 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 405 410 <span type="species:ncbi:9606">human</span>
Total RNA was isolated by extraction with TRIzol (Invitrogen), and 1 microg was reverse transcribed with random hexamers (High Capacity cDNA Archive kit; Applied Biosystems) according to the manufacturer's instructions. 5 ng cDNA was amplified in triplicate in a reaction volume of 15 microl using TaqMan Gene Expression Assay ID Hs00240928_m1 (Applied Biosystems), which is designed for the detection of human L1 cDNA, and an ABI/Prism 7900 HT thermocycler (Applied Biosystems). Preparations of RNA template without reverse transcription were used as negative controls. For each sample, the expression level of L1 was normalized to GAPDH using the comparative threshold cycle method as previously described (48).
###end p 56
###begin title 57
Adhesion assays
###end title 57
###begin p 58
###xml 199 200 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 659 660 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 692 693 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 762 767 <span type="species:ncbi:10090">mouse</span>
LECs (SV-LEC and MELC) were grown as monolayers on gelatin-coated 96-well plates and stimulated with 20 ng/ml TNF-alpha for 16 h before DC adhesion assays. DCs were labeled with 5 microM CFSE, and 105 labeled cells per well were added and incubated at 37degreesC. At the indicated time points, cells were washed and fluorescence was measured using a fluorimeter (Multilabel Counter; Wallac 1420; Perkin Elmer). After subtraction of background cell binding (assessed using BSA-coated wells), cell adhesion was calculated as follows: adhesion = BF/TF x C/A, where BF is bound fluorescence, TF is total initial fluorescence, C is the number of cells per well (105), and A is the well area (32 mm2). In some experiments, DCs were purified from cell suspensions from mouse lymph nodes using CD11c MACS MicroBeads (Miltenyi Biotec) according to the manufacturer's instructions and then FACS sorted into L1-positive and L1-negative DCs using Alexa Fluor 647-conjugated anti-L1 antibody S10.33 and PE-conjugated anti-CD11c (BD). The two DC populations were then labeled with CFSE and PKH26, respectively, before adhesion assays on SV-LEC monolayers. Cell adhesion was determined by counting green and red cells.
###end p 58
###begin p 59
###xml 202 204 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
Where specified, CFSE-labeled DCs were seeded on 96-well plates precoated with 60 microg/ml of the extracellular portion of mouse (mL1-Fc) or human (hL1-ECD) L1 in 1% gelatin. The construct for mL1-Fc (49) was a gift from M. Schachner, and the expression vector encoding histine-tagged hL1-ECD was provided by S. Silletti (University of California, San Diego, La Jolla, CA). Both recombinant proteins were expressed in 293 cells and purified from the conditioned medium by protein G (for mL1-Fc) or nickel affinity chromatography (for hL1-ECD).
###end p 59
###begin title 60
Transendothelial migration assays
###end title 60
###begin p 61
###xml 180 182 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">50</xref>
###xml 291 292 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
MELCs, SV-LECs, HUVECs, and 1G11 cells were grown as monolayers on gelatin- or fibronectin-coated Transwell inserts with a 5-microm pore (Costar; Corning) as described previously (50). ECs were stimulated with 20 ng/ml TNF-alpha for 16 h before DC transmigration assays. CFSE-labeled DCs (105 cells) were seeded onto the endothelial monolayers and incubated for different time lengths. In some experiments, MELCs and SV-LECs were grown on the lower side of the filter to determine basal-to-apical transmigration of DCs. Transwell inserts were thoroughly washed with PBS, fixed in PFA, and mounted onto microscope slides (Menzel-Glaser). Images of CFSE-labeled DCs were obtained with a microscope (Biosystems BX-71; Olympus). The number of CFSE-labeled DCs that crossed the filter was determined by counting the fluorescent cells.
###end p 61
###begin p 62
###xml 30 35 <span type="species:ncbi:9606">human</span>
The migration of CFSE-labeled human moDCs across HUVEC barriers was determined after preincubating DCs, HUVECs, or both with 30 microg/ml CE7, a monoclonal antibody with L1 blocking function properties. As a control, an isotype-matched anti-HA antibody was used at the same concentration. Cell transmigration was determined as described in the previous paragraph.
###end p 62
###begin title 63
Skin painting assay
###end title 63
###begin p 64
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 496 501 <span type="species:ncbi:10090">mouse</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 627 632 <span type="species:ncbi:10090">mouse</span>
###xml 679 684 <span type="species:ncbi:10090">mouse</span>
Mice were painted on the shaved abdomen with 0.2 ml of either 0.5% tetramethylrhodamine-5-(and-6)-isothiocyanate (5(6) (TRITC; Invitrogen) or 0.5% FITC (Sigma-Aldrich) in a 1:1 acetone/dibutylphthalate (vol/vol) mixture. Inguinal lymph nodes were excised from treated mice after 24 or 48 h and disaggregated as described in the supplemental Materials and methods. Cell suspensions from FITC-painted mice were costained with PE-conjugated anti-mouse CD11c (BD) and Alexa Fluor 647-conjugated anti-mouse L1 clone S10.33 followed by FACS analysis. Cell suspensions from TRITC-painted mice, after staining with APC-conjugated anti-mouse CD11c or with Alexa Fluor 647-conjugated anti-mouse L1 clone S10.33, were fixed and permeabilized, followed by costaining with Alexa Fluor 488-conjugated monoclonal antibody 929F3 anti-langerin (Dendritics), which recognizes the intracellular conformation of the protein (51), before FACS analysis.
###end p 64
###begin title 65
CHS assays
###end title 65
###begin p 66
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">52</xref>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
CHS was induced and determined as previously described (52). In brief, the hapten 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one (Oxazolone [OXA]; Sigma-Aldrich) was freshly prepared before CHS assays. For sensitization, mice were painted once (day 0) on the shaved abdominal skin with 100 microl of 3% OXA in 4:1 acetone/olive oil (vol/vol) solution. 5 d later (day +5), mice were challenged by the application of 10 microl OXA (1%) on each side of the right ear, whereas the left ear received the vehicle alone. CHS response was determined by measuring the thickness of the antigen-painted ear compared with that of the vehicle-treated contralateral ear by a micrometer (Mitutoyo) at 24-96 h after challenge. The results were expressed as percentage of thickness increase calculated over vehicle-treated contralateral ear.
###end p 66
###begin title 67
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
Staining of mouse endothelium
###end title 67
###begin p 68
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 516 519 <span type="species:ncbi:10116">rat</span>
###xml 662 665 <span type="species:ncbi:10116">rat</span>
###xml 722 725 <span type="species:ncbi:10116">rat</span>
###xml 731 736 <span type="species:ncbi:10090">mouse</span>
100 microl of 40 ng/ml of mouse TNF-alpha or the same volume of PBS were injected subcutaneously in the inferior abdominal region of 6-wk-old C57BL/6 mice. 16 h after the injection, mice were sacrificed and the skin around the area of injection was removed, embedded in Tissue-Tek OCT (Sakura), and snap frozen in liquid nitrogen. 5-microm frozen sections were obtained using a cryostat (CM 199; Leica) and air dried overnight. Sections were fixed in cold methanol and subjected to immunofluorescence staining using rat anti-PECAM-1 followed by Cy3-conjugated secondary antibody (Jackson ImmunoResearch Laboratories). Tissue was fixed again, blocked with excess rat IgG, and then incubated with Alexa Fluor 488-conjugated rat anti-mouse L1 (clone S10.33). The tissue was then mounted onto microscope slides and images were obtained as described for cell immunofluorescence.
###end p 68
###begin title 69
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
DC staining in mouse skin
###end title 69
###begin p 70
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 94 97 <span type="species:ncbi:10116">rat</span>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
###xml 222 226 <span type="species:ncbi:9925">goat</span>
###xml 232 235 <span type="species:ncbi:10116">rat</span>
###xml 284 288 <span type="species:ncbi:9925">goat</span>
###xml 441 444 <span type="species:ncbi:10116">rat</span>
###xml 511 514 <span type="species:ncbi:10116">rat</span>
Methanol-fixed frozen sections of C57BL/6 mouse skin were stained overnight at 4degreesC with rat anti-mouse Langerin and hamster anti-mouse CD11c. The day after, sections were incubated with an Alexa Fluor 647-conjugated goat anti-rat antibody (Invitrogen) and with a Cy3-conjugated goat anti-hamster antibody (Jackson ImmunoResearch Laboratories), followed by another fixation step in cold methanol. After an additional blocking step with rat IgG, sections were then incubated with Alexa Fluor 488-conjugated rat anti-L1 antibody (clone S10.33) for 2 h at room temperature. Stained tissues were then analyzed by confocal microscopy (TCS-SP2-AOBS; Leica).
###end p 70
###begin title 71
Online supplemental material
###end title 71
###begin p 72
###xml 277 283 277 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 299 305 299 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 288 305 288 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre;L1<sup>floxed</sup></italic>
###xml 528 534 528 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">floxed</sup>
###xml 526 534 526 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L1<sup>floxed</sup></italic>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
The supplemental Materials and methods describes the experimental procedures used for the experiments illustrated in supplemental figures. Fig. S1 shows the phenotypic analysis of L1-expressing DCs in mouse lymph nodes and spleen. Fig. S2 illustrates the characterization of L1floxed and Tie2-Cre;L1floxed mice. Fig. S3 shows the maturation of DCs in response to LPS. Fig. S4 shows the migratory response of DCs to chemokines and to the injection of FITC-labeled beads. Fig. S5 shows the reduced transendothelial migration of L1floxed DCs treated with Tat-Cre. Fig. S6 and Fig. S7 show the specific expression of L1 in Langerhans cells. Fig. S8 shows the expression of L1 in different EC types. Fig. S9 shows the role of homophilic L1-L1 interactions in the adhesion of DCs to ECs. Online supplemental material is available at .
###end p 72
###begin title 73
Supplementary Material
###end title 73
###begin title 74
[ Supplemental Material Index]
###end title 74
###begin p 75
###xml 286 290 <span type="species:ncbi:10090">mice</span>
We are grateful to M. Corada, M.R. Cera, E. Beltrami, F. Avogadri, and G. Ossolengo for technical support and to E. Dejana for insightful discussion. We thank E. Mileti, F. Morellini, M. Schachner, S. Silletti, K. Blaser, D. Piccini, A. Vecchi, and J.S. Alexander, for providing cells, mice, or reagents and M. Sixt for performing the DC motility assays in collagen.
###end p 75
###begin p 76
This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (U. Cavallaro), Telethon Foundation (U. Cavallaro), Cariplo Foundation (U. Cavallaro), Association for International Cancer Research (U. Cavallaro), Italian Ministry of Health (Ricerca Finalizzata; M. Rescigno and U. Cavallaro), Cancer Council Victoria (E.D. Williams), and Australian Health and Medical Research Council Fellowship (E.D. Williams).
###end p 76
###begin p 77
The authors have no conflicting financial interests.
###end p 77
###begin article-title 78
Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration.
###end article-title 78
###begin article-title 79
###xml 71 76 <span type="species:ncbi:9606">human</span>
Neural cell recognition molecule L1: relating biological complexity to human disease mutations.
###end article-title 79
###begin article-title 80
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Disruption of the mouse L1 gene leads to malformations of the nervous system.
###end article-title 80
###begin article-title 81
###xml 12 16 <span type="species:ncbi:10090">mice</span>
L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patterns.
###end article-title 81
###begin article-title 82
###xml 69 74 <span type="species:ncbi:9606">human</span>
Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin.
###end article-title 82
###begin article-title 83
Migration of dendritic cell subsets and their precursors.
###end article-title 83
###begin article-title 84
###xml 94 100 <span type="species:ncbi:10090">murine</span>
In vitro hematopoietic and endothelial cell development from cells expressing TEK receptor in murine aorta-gonad-mesonephros region.
###end article-title 84
###begin article-title 85
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
###end article-title 85
###begin article-title 86
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Decreased anxiety, altered place learning, and increased CA1 basal excitatory synaptic transmission in mice with conditional ablation of the neural cell adhesion molecule L1.
###end article-title 86
###begin article-title 87
###xml 43 48 <span type="species:ncbi:9606">human</span>
A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins.
###end article-title 87
###begin article-title 88
Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration.
###end article-title 88
###begin article-title 89
Migration of dendritic cells across blood and lymphatic endothelial barriers.
###end article-title 89
###begin article-title 90
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Generation and characterization of a mouse lymphatic endothelial cell line.
###end article-title 90
###begin article-title 91
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Isolation and characterization of a novel mouse lymphatic endothelial cell line: SV-LEC.
###end article-title 91
###begin article-title 92
###xml 59 65 <span type="species:ncbi:10090">murine</span>
###xml 131 137 <span type="species:ncbi:10090">murine</span>
A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants.
###end article-title 92
###begin article-title 93
Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes.
###end article-title 93
###begin article-title 94
Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response.
###end article-title 94
###begin article-title 95
Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.
###end article-title 95
###begin article-title 96
Tolerogenic dendritic cells.
###end article-title 96
###begin article-title 97
Langerin expressing cells promote skin immune responses under defined conditions.
###end article-title 97
###begin article-title 98
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 108 117 <span type="species:ncbi:10090">nude mice</span>
Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.
###end article-title 98
###begin article-title 99
L1 (CD171) is highly expressed in gastrointestinal stromal tumors.
###end article-title 99
###begin article-title 100
The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.
###end article-title 100
###begin article-title 101
L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.
###end article-title 101
###begin article-title 102
The adhesion molecule L1 (CD171) promotes melanoma progression.
###end article-title 102
###begin article-title 103
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.
###end article-title 103
###begin article-title 104
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human neural cell adhesion molecule L1 functions as a costimulatory molecule in T cell activation.
###end article-title 104
###begin article-title 105
Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium.
###end article-title 105
###begin article-title 106
###xml 71 76 <span type="species:ncbi:9606">human</span>
The L1 adhesion molecule supports alpha v beta 3-mediated migration of human tumor cells and activated T lymphocytes.
###end article-title 106
###begin article-title 107
The Arg-Gly-Asp motif in the cell adhesion molecule L1 promotes neurite outgrowth via interaction with the alphavbeta3 integrin.
###end article-title 107
###begin article-title 108
Plasmin-sensitive dibasic sequences in the third fibronectin-like domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitment.
###end article-title 108
###begin article-title 109
Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells.
###end article-title 109
###begin article-title 110
Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells.
###end article-title 110
###begin article-title 111
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Selective malformation of the splenic white pulp border in L1-deficient mice.
###end article-title 111
###begin article-title 112
L1 antibodies block lymph node fibroblastic reticular matrix remodeling in vivo.
###end article-title 112
###begin article-title 113
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice.
###end article-title 113
###begin article-title 114
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Altered distribution of dopaminergic neurons in the brain of L1 null mice.
###end article-title 114
###begin article-title 115
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1.
###end article-title 115
###begin article-title 116
In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.
###end article-title 116
###begin article-title 117
The L1 cell adhesion molecule as a target for radioimmunotherapy.
###end article-title 117
###begin article-title 118
Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins.
###end article-title 118
###begin article-title 119
Anti-neuroblastoma antibody chCE7 binds to an isoform of L1-CAM present in renal carcinoma cells.
###end article-title 119
###begin article-title 120
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.
###end article-title 120
###begin article-title 121
###xml 99 121 99 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella typhimurium</italic>
###xml 99 121 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti-Salmonella typhimurium immunity.
###end article-title 121
###begin article-title 122
###xml 42 47 <span type="species:ncbi:9606">human</span>
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.
###end article-title 122
###begin article-title 123
Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant.
###end article-title 123
###begin article-title 124
Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
###end article-title 124
###begin article-title 125
Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis.
###end article-title 125
###begin article-title 126
Prevention of neuronal cell death by neural adhesion molecules L1 and CHL1.
###end article-title 126
###begin article-title 127
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells.
###end article-title 127
###begin article-title 128
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation.
###end article-title 128
###begin article-title 129
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75.
###end article-title 129
###begin p 130
###xml 153 158 <span type="species:ncbi:9606">human</span>
Abbreviations used: CAM, cell adhesion molecule; cDNA, complementary DNA; CHS, contact hypersensitivity; EC, endothelial cell; HA, hemagglutinin; HUVEC, human umbilical vein EC; LEC, lymphatic EC; moDC, monocyte-derived DC.
###end p 130

